MAPT and Alzheimer disease: In this context, we believe that there are margins for potentially therapeutic interventions against AD, using multifunctional peptides that are capable of inhibiting Aβ/tau co-aggregation by also modulating metal driven cross-interactions between Aβ and tau protein in specific, biologically relevant, compartments including the cell membrane interface.